Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.385
Filtrar
1.
Soins ; 64(841): 26-29, 2019 Dec.
Artigo em Francês | MEDLINE | ID: mdl-31864508

RESUMO

The ageing of the French population and the high occurrence of cancers in the population of patients aged over 75 has resulted in the convergence of the competences of two specialties, oncology and geriatrics, in order to optimise the quality of the care provided. Geriatric oncology care must be adapted to the medical, psychological and social situation of each patient.


Assuntos
Geriatria/organização & administração , Oncologia/organização & administração , Neoplasias/terapia , Idoso , França/epidemiologia , Humanos , Neoplasias/epidemiologia , Qualidade da Assistência à Saúde
2.
Soins ; 64(841): 30-33, 2019 Dec.
Artigo em Francês | MEDLINE | ID: mdl-31864509

RESUMO

With around 1 800 new cases each year in children under the age of 15 and 800 new cases a year in teenagers, childhood cancers are a major public health issue. Chemotherapy remains a key component in the treatment of childhood cancers but the advances made in genetics has opened the way to targeted therapies which enable the treatment to be adapted to each child significantly improving survival and reducing sequelae.


Assuntos
Oncologia/organização & administração , Neoplasias/tratamento farmacológico , Pediatria/organização & administração , Adolescente , Criança , Humanos
3.
Soins ; 64(841): 46-49, 2019 Dec.
Artigo em Francês | MEDLINE | ID: mdl-31864513

RESUMO

In the often long and difficult care pathway of patients with cancer, the oncology care network has an important role to play. Of all the coordination programmes, it is the one which enables the patient's medical and psychosocial situation to be constantly evaluated throughout their illness.


Assuntos
Oncologia/organização & administração , Neoplasias/terapia , Humanos
4.
Soins ; 64(841): 52-55, 2019 Dec.
Artigo em Francês | MEDLINE | ID: mdl-31864515

RESUMO

In many countries, health systems are facing major difficulties in maintaining the quality, continuity and safety of the care provision. That is why healthcare systems are being reformed across the world. These reforms are redefining the boundaries between medical and paramedical professions, and have resulted in the emergence of advanced practices, notably in nursing. The field of oncology is not immune from these issues. It must deal with the evolution of techniques and technologies, the increase in knowledge as well as an evolution in the needs of patients with cancer. In France, advanced practice nurses appear to have found their place in oncology as they can take an active part in the priorities fixed by the different national cancer plans, notably through the prevention role which is one of the objectives.


Assuntos
Prática Avançada de Enfermagem , Oncologia/organização & administração , França , Humanos
5.
Semin Oncol ; 46(4-5): 308-313, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31711680

RESUMO

Cancer clinical trials represent an important option for patients with a diagnosis of cancer and the clinician-investigators involved in their care who seek options for their disease. For all who are impacted by cancer, these studies offer opportunities for greater learning. Conducting these important studies involves several challenges, including recruiting eligible participants. To address barriers that arise over the course of these activities, the Department of Veterans Affairs (VA) and National Cancer Institute (NCI) have partnered to increase Veteran participation in oncology clinical trials. This initiative, the NCI And VA Interagency Group to Accelerate Trials Enrollment, or NAVIGATE, is focused on addressing recruitment across the VA healthcare system and finding systematic solutions related to activating, recruiting for and conducting oncology clinical trials at VA Medical Centers. Additional goals include (1) establishing a sustainable network that can serve as a model for other VA sites interested in doing cancer clinical trials, (2) recruitment of minority patients, and (3) developing best practices and policies that can be deployed across the VA healthcare system. In this manuscript, we describe the scope, organization, activities, and future directions of NAVIGATE while also highlighting key needs for successfully conducting cancer clinical trials within the VA system. This partnership between 2 large federal agencies with a shared commitment to improving cancer care may provide lessons to others who are also dedicated to helping those affected by the disease.


Assuntos
Ensaios Clínicos como Assunto/organização & administração , Oncologia/organização & administração , Administração dos Cuidados ao Paciente/organização & administração , Humanos , Oncologia/métodos , Oncologia/normas , National Cancer Institute (U.S.) , Assistência ao Paciente , Melhoria de Qualidade , Estados Unidos , United States Department of Veterans Affairs
9.
Cancer Control ; 26(1): 1073274819863802, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31319695

RESUMO

Although the burden of cancer is rapidly growing in Vietnam, there was no up-to-date review that describes cancer burden and control in Vietnam throughout the literature. By identifying various risk factors, means of prevention, and methods for early detection, this review seeks to systematically summarize the evidence for the future planning and management of cancer occurrence in Vietnam. Additionally, this report aims to identify improvements which are necessary for the treatment and palliative care of patients with cancer in Vietnam. We employed a hybrid approach including both a scoping review and narrative synthesis for this study. Information was identified, extracted, and charted from various sources, which include international and domestically published studies, in addition to gray literature. Our results illustrate that the burden of cancer in Vietnam has tripled in the past 30 years, and this situation could be partly explained by the growing prevalence of both old and new risk factors. Besides hepatitis B virus, various other important risk factors such as human papilloma virus, tobacco usage, physical inactivity, and improper diets are still not under control in Vietnam. There is presently a lack of national cancer screening programs, and the capacity of cancer care services could not maintain pace with the demands of a rapidly increasing Vietnamese population. Overall, policy frameworks for cancer control in Vietnam are in place, but there is still a lack of proper financing and governing models necessary to support a sustainable program. In conclusion, Cancer and its associated consequences are both persistent and emerging problems in Vietnam, and the results of cancer control programs are limited. A comprehensive and evidence-based approach toward the prevention and treatment of cancer should be the future direction for Vietnam.


Assuntos
Efeitos Psicossociais da Doença , Assistência à Saúde/organização & administração , Medicina Baseada em Evidências/organização & administração , Oncologia/organização & administração , Neoplasias/epidemiologia , Assistência à Saúde/métodos , Assistência à Saúde/tendências , Detecção Precoce de Câncer/métodos , Detecção Precoce de Câncer/tendências , Medicina Baseada em Evidências/métodos , Medicina Baseada em Evidências/tendências , Implementação de Plano de Saúde , Humanos , Oncologia/métodos , Oncologia/tendências , Neoplasias/terapia , Cuidados Paliativos/métodos , Cuidados Paliativos/organização & administração , Cuidados Paliativos/tendências , Prevalência , Fatores de Risco , Desenvolvimento Sustentável , Vietnã/epidemiologia
10.
J Oncol Pharm Pract ; 25(8): 1945-1967, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31288634

RESUMO

INTRODUCTION: Although many oncology pharmacists are embedded members within the healthcare team, data documenting their contributions to optimal patient outcomes are growing. The purpose of this paper is to demonstrate the value of the oncology pharmacist within the healthcare team and describe the knowledge, skills, and functions of the oncology pharmacist. METHODS: A systematic literature review of articles that were published on PubMed between January 1951 and October 2018 was completed. Identified abstracts were reviewed and included if they focused on measuring the value or impact of the oncology pharmacist on provider/patient satisfaction, improvement of medication safety, improvement of quality/clinical care outcomes, economics, and intervention acceptance. Review articles, meta-analysis, and studies not evaluating oncology pharmacist activities were excluded. Studies were thematically coded into four themes (clinical care, patient education, informatics, and cost savings) by 10 oncology pharmacists. RESULTS: Four-hundred twenty-two articles were identified, in which 66 articles met inclusion criteria for this review. The selected literature included 27 interventional and 38 descriptive studies. The value of the oncology pharmacist was demonstrated by published articles in four key themes: clinical care, patient education, informatics, and cost savings. CONCLUSION: With an expected shortage of oncology physicians and the ongoing development of complex oncology therapies, the board-certified oncology pharmacist is well suited to serve as a physician extender alongside nurse practitioners and/or physician assistants as the medication expert on the oncology care team. The demonstrated value of the oncology pharmacist supports their role as frontline providers of patient care.


Assuntos
Oncologia/organização & administração , Equipe de Assistência ao Paciente/organização & administração , Farmacêuticos/organização & administração , Redução de Custos , Humanos , Médicos/organização & administração , Papel Profissional
11.
Nat Rev Cancer ; 19(9): 489-493, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31358894

RESUMO

Cancer research relies on key values such as creativity, collaboration, research integrity and resource sharing. A positive research environment which fosters these key values is becoming a decisive factor for some funders and research institutions. To create a supportive research culture in laboratories, the training and mentoring of young scientists is important. However, the fast-paced and fierce competition for funding and jobs can present a challenge to the younger generation of scientists who depend on the guidance and mentorship of scientific leaders. The annual Nature Awards for Mentoring in Science have been created to bring attention to one of the most essential but least recognized skills in scientific leadership. Thus far, 35 scientists from across the world, who are working in a range of disciplines, have been recognized by this award for their outstanding scientific mentorship. In this Viewpoint, we have asked three recipients of this award who work in fields associated with cancer research about their views on good mentoring, and how a revised approach to mentorship can help to achieve a positive research culture and contribute to scientific discovery.


Assuntos
Pesquisa Biomédica/organização & administração , Oncologia/organização & administração , Tutoria , Mentores , Distinções e Prêmios , Pesquisa Biomédica/educação , Escolha da Profissão , Humanos , Relações Interprofissionais , Liderança , Oncologia/educação , Modelos Organizacionais
12.
Medicine (Baltimore) ; 98(25): e16050, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31232941

RESUMO

BACKGROUND: miR-222 is one of the most consistently overexpressed miRNAs in papillary thyroid carcinoma (PTC). Previous studies demonstrated that miR-222 overexpression conferred high-risk features in PTC patients, suggesting its value in risk-stratification. However, studies in term of miR-222's utility on stratifying PTCs are lacking. METHODS: One hundred patients including 10 with multinodular goiter and 90 with PTC were enrolled. Formalin-fixed paraffin-embedded samples were exploited for miR-222 quantitative reverse transcriptase- polymerase chain reaction (RT-PCR) analysis. Correlations between miR-222 expression and different clinicopathological features, Tumor-node-metastasis (TNM) staging and ATA risk level were analyzed. RESULTS: miR-222 expression of the PTC group was significantly higher than that of the goiter group (P < .001). Furthermore, miR-222 expression was significantly higher in PTCs with advanced features like larger tumor, capsular invasion, vascular invasion and lymph nodes metastasis. The majority of patients (61%) were in stage I group (similar to ATA low-risk) by TNM staging system. As to the ATA system, the majority (73%) were in intermediate-risk group (similar to TNM stage II and III roughly). Contrary to previous report, here we found that miR-222 expression was correlated with the ATA risk level (P < .001), but not with the TNM staging (P = .122). CONCLUSION: In the present study, we demonstrated that miR-222 overexpression was correlated with advanced features like capsular invasion, vascular invasion, larger tumor size and lymph node metastasis in PTCs. Most importantly, miR-222 expression was correlated with ATA risk levels, suggesting its potential value in PTC risk-stratification.


Assuntos
MicroRNAs/análise , Medição de Risco/métodos , Câncer Papilífero da Tireoide/classificação , Adolescente , Adulto , Idoso , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/biossíntese , Biomarcadores Tumorais/sangue , China , Feminino , Humanos , Masculino , Oncologia/organização & administração , MicroRNAs/biossíntese , MicroRNAs/sangue , Pessoa de Meia-Idade , Prognóstico , Câncer Papilífero da Tireoide/sangue
13.
Support Care Cancer ; 27(8): 2755-2756, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31053971

RESUMO

This commentary deals with the need of an early integration between hematologist and palliative care specialists as well as pain therapists as a routine basis in order to ensure the best management of patients affected by acute leukemia from the onset of the disease and in the stages of causal therapy. This strategy could limit the burden of painful symptoms and, in addition, avoid unnecessary suffering to patients, ensuring the best conditions for optimal outcome of these patients with extremely high clinical complexity and symptomatology who receive intensive treatments or who are managed with novel treatment approaches.


Assuntos
Dor do Câncer/complicações , Dor do Câncer/terapia , Hematologia/métodos , Leucemia Mieloide Aguda/terapia , Oncologia/métodos , Manejo da Dor/métodos , Cuidados Paliativos/métodos , Dor do Câncer/epidemiologia , Hematologia/organização & administração , Hematologia/normas , Humanos , Comunicação Interdisciplinar , Leucemia Mieloide Aguda/complicações , Oncologia/organização & administração , Oncologia/normas , Dor/complicações , Dor/etiologia , Manejo da Dor/efeitos adversos , Equipe de Assistência ao Paciente/organização & administração , Equipe de Assistência ao Paciente/normas
14.
Br J Hosp Med (Lond) ; 80(5): 252-257, 2019 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-31059337

RESUMO

A majority of cancer cases now occur among older people, but this group is less likely to receive treatment and outcomes are poorer than in younger people. Age by itself can be a poor predictor of who will benefit from treatment with surgery, chemotherapy or radiotherapy. Comprehensive geriatric assessment is a multidisciplinary, multidomain process that helps to identify frailty, which is associated with increased mortality. Comprehensive geriatric assessment highlights areas that should be optimized before treatment and helps support a shared decision-making approach. Geriatricians, oncologists and surgeons now work together to help assess and support older people with cancer.


Assuntos
Avaliação Geriátrica/métodos , Neoplasias/terapia , Afeto , Idoso , Idoso de 80 Anos ou mais , Cognição , Comorbidade , Meio Ambiente , Fragilidade/epidemiologia , Geriatria/organização & administração , Humanos , Oncologia/organização & administração , Neoplasias/epidemiologia , Estado Nutricional , Equipe de Assistência ao Paciente/organização & administração , Desempenho Físico Funcional , Qualidade de Vida , Apoio Social
15.
Acta Oncol ; 58(7): 1015-1020, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30958083

RESUMO

Background: Healthcare personnel are responsible for providing patient-centered care regardless of their patients' language skills, but language barriers is identified as the main hindrances providing effective, equitable and safe care to patients with limited proficiency in a country's majority language. This study is a national multisite cross-sectional survey aiming to investigate communication over language barriers in pediatric oncology care. Material and Methods: A survey using the Communication over Language Barriers questionnaire (CoLB-q) distributed to medical doctors, registered nurses and nursing assistants at six pediatric oncology centers in Sweden (response rate 90%) using descriptive statistical analyses. Results: Professional interpreters on site were the most common solution when using an interpreter, although relatives or even children were used. The use of professional interpreters on site differed among the professions and in different clinical situations, such as medical encounter, education or procedure preparation. All professions reported that the use of professional interpreters greatly increased care relationships, patient safety and patient involvement in care. Conclusions: Healthcare personnel seem to believe that professional interpreters are crucial when caring for patients and family members who do not speak the majority language, but there is an obvious discrepancy between this belief and their use of professional interpreters.


Assuntos
Barreiras de Comunicação , Oncologia/estatística & dados numéricos , Neoplasias/terapia , Relações Profissional-Paciente , Tradução , Criança , Estudos Transversais , Feminino , Pessoal de Saúde/organização & administração , Pessoal de Saúde/estatística & dados numéricos , Humanos , Masculino , Oncologia/organização & administração , Neoplasias/diagnóstico , Participação do Paciente/estatística & dados numéricos , Participação do Paciente/tendências , Segurança do Paciente , Inquéritos e Questionários/estatística & dados numéricos , Suécia
17.
Support Care Cancer ; 27(8): 2757-2759, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31001693

RESUMO

PURPOSE: The implementation of a new online conference tool, with the goal of providing competent answers, information, and support from experts in their fields, about diagnosis, treatment, and rehabilitation in breast cancer patients. METHODS: The implementation process and data of the first online conference are described. RESULTS: Following the idea and initiative of a breast cancer survivor, and under the umbrella of a leading oncologist in breast cancer treatment, and with the cooperation of further leading experts in the fields, plus their therapeutic teams, the new online conference SURVIVA 2018 was implemented as an innovative platform-free of charge, online, and with easy and anonymous access-to provide breast cancer survivors with in-depth information and help from the leading Austrian experts in their fields. This first online conference for German-speaking breast cancer survivors is an innovative and modern concept, which seems to have been very well accepted. CONCLUSION: This concept could also be of interest to survivors of other cancer entities.


Assuntos
Neoplasias da Mama/reabilitação , Sobreviventes de Câncer/educação , Congressos como Assunto/organização & administração , Disseminação de Informação/métodos , Internet , Oncologia/organização & administração , Áustria/epidemiologia , Neoplasias da Mama/terapia , Sobreviventes de Câncer/estatística & dados numéricos , Congressos como Assunto/normas , Prova Pericial , Feminino , Humanos , Invenções/tendências , Educação de Pacientes como Assunto/métodos , Grupos de Autoajuda
19.
Support Care Cancer ; 27(12): 4497-4505, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30911916

RESUMO

Recent calls from oncology providers and cancer policy forums advocate for improved connections between rehabilitation services and cancer care delivery. Traditionally, this intersection has occurred when patients present with overt disability related to cancer treatment and is driven by reactive approaches to care. A growing body of evidence suggests that a proactive approach to functional screening and assessment encourages the identification and management of functional impairment and morbidity earlier in the cancer care continuum and contributes to better outcomes. A clinical pathway that prompts screening and referral to rehabilitation services in an expedited manner is needed. Cancer patient navigators provide care coordination through the duration of medical treatment, survivorship, and end-of-life. This article presents a framework for navigation workflows to support functional assessment and provide early triage pathways to the rehabilitation system of care. We provide a case example of novel approach to patient navigation from a Southeastern United States community cancer center that uses a patient navigator with a rehabilitation background to serve in this role. An overview of the position skills, functional assessment and referral pathways, and perspective on quality improvements related to this approach are described. The use of rehabilitation providers beyond traditional clinical roles should be further explored. Their expertise in functional assessment and interpretation could foster improvements in cancer care delivery and outcomes for survivors in both the short and long term.


Assuntos
Oncologia/organização & administração , Neoplasias/reabilitação , Neoplasias/terapia , Navegação de Pacientes/organização & administração , Reabilitação/organização & administração , Continuidade da Assistência ao Paciente/organização & administração , Assistência à Saúde/organização & administração , Humanos , Oncologia/métodos , Navegação de Pacientes/métodos , Reabilitação/métodos , Sobreviventes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA